22
22% decline in SP since 30.06.2017 off a 12 month low says it all really. A very very poor result.
Everything that happened in between is academic if you look at SP. what matters to us all is performing SP to make money.
I could type in many things that are +++ e,f CF+ in 2018 and ---- about this company however one fundamental thing that I don't like the fact is the new management board are mainly comprised of ex pharma people where clearly the future is medical device here and most people would agree on back of recent vaccine results better to divest and not plough further money in. If we see another decline on this in next FY then i would hope & expect some changes again in management.
AHZ FY18, page-10
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.35 |
Change
0.040(0.22%) |
Mkt cap ! $352.7M | |||
| Open | High | Low | Value | Volume |
| $19.00 | $19.00 | $18.13 | $69.15K | 3.766K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 383 | $18.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.50 | 1000 | 1 |
View Market Depth
| Last trade - 15.59pm 02/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |